Jean-Pierre Grégoire is a Scientist with the Population Health and Optimal Health Practices Research Unit at the CHU de Québec-Laval University Research Center. He is also a Professor and a former Dean (2006-2011) at the Faculty of Pharmacy at Laval University. Professor Grégoire is a former President of the Quebec Order of Pharmacists (1993-1995) and of the Canadian Council for the Accreditation of Pharmacy Programs (2000). He is on the Evaluation Commission of the “Conférence des Doyens de Facultés de Pharmacie d’expression Française” (CIDPHARMEF) for which he has led several external assessments of Faculties of Pharmacy in France, Africa, and Asia.
Professor Grégoire is a Fellow of the International Society for Pharmacoepidemiology and of the Canadian Academy of Health Sciences.
Optimal use of drugs
In recent years, his research has focused on the optimization of drug use in chronic diseases such as hypertension, heart failure, diabetes, and schizophrenia. He has published extensively on the issue of non-adherence to drug treatments.
1050, chemin Sainte-Foy
Canada G1S 4L8
Appropriateness of Ticagrelor Use at Initiation: A Population-Based Cohort Study.Journal Article
J Pharm Pharm Sci, 22 (1), pp. 1-9, 2019.
Response to letter to the editor related to the retraction of a trial included in a meta-analysis of interventions to enhance oral medication adherence titled "Effectiveness and content analysis of interventions to enhance oral antidiabetic drug adherence in adults with type 2 diabetes: Systematic review and meta-analysis".Journal Article
Value Health, 22 (2), pp. 264-266, 2019, ISSN: 1098-3015.
Risk of pulmonary toxicity of bleomycin and filgrastim.Journal Article
J Oncol Pharm Pract, pp. 1078155218804293, 2018, ISSN: 1078-1552.
Neighbourhood Material and Social Deprivation and Exposure to Antidepressant Drug Treatment: A Cohort Study Using Administrative Data.Journal Article
Can J Psychiatry, 63 (10), pp. 701-711, 2018, ISSN: 0706-7437.
Measuring adherence to oral antidiabetic multi-drug treatment: Comparative validity of prescription claims-based adherence measures against hospitalization.Journal Article
Res Social Adm Pharm, 2018, ISSN: 1551-7411.
The Development of a Community Pharmacy-Based Intervention to Optimize Patients' Use of and Experience with Antidepressants: A Step-by-Step Demonstration of the Intervention Mapping Process.Journal Article
Pharmacy (Basel), 6 (2), 2018, ISSN: 2226-4787.
Patient perspectives on the role of community pharmacists for antidepressant treatment: A qualitative study.Journal Article
Can Pharm J (Ott), 151 (2), pp. 142-148, 2018, ISSN: 1715-1635.
Association between community pharmacy loyalty and persistence and implementation of antipsychotic treatment among individuals with schizophrenia.Journal Article
Res Social Adm Pharm, 14 (1), pp. 53-61, 2018, ISSN: 1551-7411.
Factors associated with adherence to asthma treatment with inhaled corticosteroids: A cross-sectional exploratory study.Journal Article
J Asthma, 55 (3), pp. 318-329, 2018, ISSN: 0277-0903.
Adherence to the evidence-based heart failure drug treatment: Are there sex-specific differences among new users?Journal Article
Res Social Adm Pharm, 14 (10), pp. 915-920, 2018, ISSN: 1551-7411.
- Centre hospitalier universitaire de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
Recently finished projects
- Enhancing adherence to adjuvant endocrine therapy among breast cancer survivors: Pilot study of the S.O.I.E. program, Subvention, Instituts de recherche en santé du Canada, Volet Projet: Concours pilotes, from 2016-04-01 to 2018-04-30
- « Soasga ziiga », plateforme d’implication des usagers dans la recherche pour l’amélioration de la santé maternelle et infantile au Burkina Faso, Subvention, Instituts de recherche en santé du Canada, Autre : Recherche axée sur le patient : Subventions de collaboration, from 2018-03-01 to 2019-02-28